Actinic Keratosis
From the Journals
Less pain, same gain with tirbanibulin for actinic keratosis
The results, assessed at day 57 and out to 1 year of follow-up, were associated with recurrence of lesions at 1 year.
Article
Scaly lesion on forearm
Case Reports
Erythema Ab Igne and Malignant Transformation to Squamous Cell Carcinoma
Erythema ab igne (EAI) is a cutaneous reaction in response to prolonged exposure to infrared heat sources at temperatures insufficient to induce a...
Conference Coverage
New AK treatments: Local reactions are the price for greater clearance rates
Like current treatments effective for actinic keratosis, coming therapies are likely to trade tolerability for efficacy.
Original Research
CO2 Laser Ablative Fractional Resurfacing Photodynamic Therapy for Actinic Keratosis and Nonmelanoma Skin Cancer: A Randomized Split-Side Study
Aminolevulinic acid photodynamic therapy (PDT) is a preferred method for treatment of multiple actinic keratoses in broad skin areas (referred to...
Latest News
EU panel review supports decision to pull Picato from market
The review found “a higher occurrence of skin cancers, especially squamous cell carcinoma, in areas of skin treated with Picato than in areas...
Case Letter
Inflammatory Changes in Actinic Keratoses Associated With Afatinib Therapy
One of the underreported adverse events of afatinibis is the induction of inflammatory changes in actinic keratoses (AKs).
Conference Coverage
Short-course calcipotriol plus 5-FU for AKs: potential major public health impact
LAHAINA, HAWAII – Four days of field therapy brought 3 years of protection against SCC development.
Latest News
European marketing of Picato suspended while skin cancer risk reviewed
The Food and Drug Administration is gathering information to investigate the safety concern raised in Europe.
Conference Coverage
Treating AKs with PDT, other options
SEATTLE – A study comparing nanoemulsion of ALA and MAL found the nanoemulsion to be superior in achieving complete resolution of all lesions at...